Literature DB >> 16081997

Molecular detection of Cellulosimicrobium cellulans as the etiological agent of a chronic tongue ulcer in a human immunodeficiency virus-positive patient.

Beate Heym1, Pierre Gehanno, Véronique Friocourt, Marie-Elisabeth Bougnoux, Michèle Le Moal, Corinne Husson, Jacques Leibowitch, Marie-Hélène Nicolas-Chanoine.   

Abstract

Ulcerations appeared on the tongue of a 48-year-old human immunodeficiency virus-positive man. Histological findings of the biopsy specimen and the fact that the patient had resided in Louisiana led us to suspect "American histoplasmosis". A new ulcer appeared while the patient was being treated with itraconazole, and the gene for 16S rRNA of Cellulosimicrobium cellulans was amplified. The lesions healed during treatment with oral penicillin and azithromycin.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16081997      PMCID： PMC1234009          DOI： 10.1128/JCM.43.8.4269-4271.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  The biodiversity of microbial cytochromes P450.

Authors:  Steven L Kelly; David C Lamb; Colin J Jackson; Andrew G Warrilow; Diane E Kelly
Journal:  Adv Microb Physiol       Date:  2003       Impact factor: 3.517

2.  Actinomycosis presenting as an oral ulcer in a neutropenic patient.

Authors:  Amit Verma; Wendy Stock; Marcy Lait; Karen Ferrer; John Quinn; Leonidas C Platanias
Journal:  South Med J       Date:  2002-09       Impact factor: 0.954

3.  Reclassification of Cellulomonas cellulans (Stackebrandt and Keddie 1986) as Cellulosimicrobium cellulans gen. nov., comb. nov.

Authors:  P Schumann; N Weiss; E Stackebrandt
Journal:  Int J Syst Evol Microbiol       Date:  2001-05       Impact factor: 2.747

Review 4.  Acute oral ulcers.

Authors:  Alison J Bruce; Roy S Rogers
Journal:  Dermatol Clin       Date:  2003-01       Impact factor: 3.478

5.  [Postoperative meningitis and prolonged fever. Repeated isolation of Brevibacterium fermentans. Pathogenic hypotheses].

Authors:  J Fleurette; A Moulin; P Monnet; C Lapras
Journal:  Ann Inst Pasteur (Paris)       Date:  1969-03

Review 6.  Molecular basis of resistance to azole antifungals.

Authors:  Antonella Lupetti; Romano Danesi; Mario Campa; Mario Del Tacca; Steven Kelly
Journal:  Trends Mol Med       Date:  2002-02       Impact factor: 11.951

7.  Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis.

Authors:  C J Jackson; D C Lamb; D E Kelly; S L Kelly
Journal:  FEMS Microbiol Lett       Date:  2000-11-15       Impact factor: 2.742

Review 8.  Oral fungal and bacterial infections in HIV-infected individuals: an overview in Africa.

Authors:  T A Hodgson; C C Rachanis
Journal:  Oral Dis       Date:  2002       Impact factor: 3.511

9.  Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.

Authors:  Kirsty J McLean; Ker R Marshall; Alison Richmond; Iain S Hunter; Kay Fowler; Tobias Kieser; Sudagar S Gurcha; Gurydal S Besra; Andrew W Munro
Journal:  Microbiology       Date:  2002-10       Impact factor: 2.777

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962
View more
  8 in total

1.  Clearance of Cellulosimicrobium cellulans bacteremia in a child without central venous catheter removal.

Authors:  Marie-Claire Rowlinson; David A Bruckner; Claudia Hinnebusch; Karin Nielsen; Jaime G Deville
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Early-onset neonatal sepsis due to Cellulosimicrobium cellulans.

Authors:  M Casanova-Román; A Sanchez-Porto; J L Gomar; M Casanova-Bellido
Journal:  Infection       Date:  2010-04-08       Impact factor: 3.553

3.  Septic arthritis due to Cellulosimicrobium cellulans.

Authors:  César Magro-Checa; Lara Chaves-Chaparro; Jorge Parra-Ruiz; Alejandro Peña-Monje; José Luis Rosales-Alexander; Juan Salvatierra; Enrique Raya
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

4.  Endogenous endophthalmitis caused by bacteria with unusual morphology in direct microscopic examination of the vitreous.

Authors:  Sarita Kar; Soumyava Basu; Savitri Sharma; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

5.  Draft Genome Sequence of Multidrug-Resistant Cellulosimicrobium sp. Strain KWT-B, Isolated from Feces of Hirundo rustica.

Authors:  Takehiko Kenzaka; Yuina Ishimoto; Katsuji Tani
Journal:  Genome Announc       Date:  2017-07-13

6.  Targeted isolation and cultivation of uncultivated bacteria by reverse genomics.

Authors:  Karissa L Cross; James H Campbell; Manasi Balachandran; Alisha G Campbell; Connor J Cooper; Ann Griffen; Matthew Heaton; Snehal Joshi; Dawn Klingeman; Eugene Leys; Zamin Yang; Jerry M Parks; Mircea Podar
Journal:  Nat Biotechnol       Date:  2019-09-30       Impact factor: 68.164

7.  Draft Genome Sequence of Cellulosimicrobium sp. Strain MM, Isolated from Arsenic-Rich Microbial Mats of a Himalayan Hot Spring.

Authors:  Anukriti Sharma; Princy Hira; Mallikarjun Shakarad; Rup Lal
Journal:  Genome Announc       Date:  2014-10-09

8.  A case report of the differential diagnosis of Cellulosimicrobium cellulans-infected endocarditis combined with intracranial infection by conventional blood culture and second-generation sequencing.

Authors:  Huifang Zhang; Chunyan He; Rui Tian; Ruilan Wang
Journal:  BMC Infect Dis       Date:  2020-11-26       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.